重症医学随机对照实效试验共同入组考量:SPICE-8共同入组指南
澳大利亚与新西兰重症监护学会临床试验组等研究者主导的试验组已发布考虑共同入组的政策和指南,但均未提供评估共同入组申请的标准清单,导致此类申请通常按个案处理。作者基于SPICE III随机对照试验的经验,提出八项广泛适用的标准(SPICE-8标准),共同入组应在满足这些标准后方可批准。出于监管目的和出版物中报告共同入组并不常见,部分原因是解释缺乏合理共同入组效应较为复杂。作者建议注明符合这些标准可简化此类报告并提高透明度。
要点
- 作者基于SPICE III随机对照试验经验提出SPICE-8八项标准,共同入组应在满足这些标准后方可批准。
- 现有政策和指南未提供评估共同入组申请的标准清单,此类申请通常按个案处理。
- 作者建议注明符合SPICE-8标准可简化共同入组的监管报告和发表报告并提高透明度。
- 出于监管目的和出版物中报告共同入组并不常见,部分原因是解释缺乏合理共同入组效应较为复杂。
诊断标准与关键阈值
- SPICE-8标准:作者提出八项广泛适用的标准,共同入组应在满足这些标准后方可批准;原文未逐条列出八项标准的具体内容。
研究设计与关键结果
- 作者基于SPICE III随机对照试验的经验,提出八项广泛适用的标准(SPICE-8标准),共同入组应在满足这些标准后方可批准。
- 现有政策和指南未提供评估共同入组申请的标准清单,此类申请通常按个案处理。
- 出于监管目的和出版物中报告共同入组并不常见,部分原因是解释缺乏合理共同入组效应较为复杂。
证据类型、等级与局限
- 证据类型:基于SPICE III随机对照试验经验的指南(SPICE-8共同入组指南)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者建议注明符合SPICE-8标准可简化共同入组的监管报告和发表报告并提高透明度。
- 作者提出共同入组应在满足SPICE-8八项标准后方可批准,而非按个案临时评估。
指南或共识出处
- SPICE-8共同入组指南(Considerations for co-enrolment in randomised controlled effectiveness trials in critical care: the SPICE-8 co-enrolment guidelines),发表于Crit Care Resusc。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
The Australian and New Zealand Intensive Care Society Clinical Trials Group and other investigator-led trials groups in critical care publish policies and guidelines outlining the rationale for considering co-enrolment in large, randomised controlled trials in intensive care medicine. However, none present a checklist of criteria by which a request for permission to co-enrol in an existing trial can be assessed. Consequently, such requests tend to be made and assessed on an ad hoc basis. Based on our experience in the SPICE III randomised controlled trial, we propose eight broadly applicable criteria (the SPICE-8 criteria) to be satisfied before co-enrolment should be approved. Reporting co-enrolment in trials, for regulatory purposes and in publications, is uncommon, partly because of the complexity involved in explaining a lack of a plausible coenrolment effect. We suggest that noting compliance with these criteria would simplify such reporting and enhance transparency.
参考来源
- Reade MC, Bass F, Howe B, et al. Considerations for co-enrolment in randomised controlled effectiveness trials in critical care: the SPICE-8 co-enrolment guidelines. Crit Care Resusc. 2017. PMID: 28651505
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。